series-c-plus
Stage
1
Investors
About
Advaxis was an American biotechnology company focused on the discovery, development, and commercialization of immunotherapies based on a genetically engineered platform using Listeria monocytogenes (Lm). The company merged with Ayala Pharmaceuticals in January 2023.
Explore Advaxis's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.